This move is archived. Current quotes and coverage live on the stock page.
Get CSCI alerts:

COSCIENS Biopharma Inc. has surged by 7.28% in today's trading session, capturing the attention of investors.
In a remarkable turn of events, COSCIENS Biopharma Inc. (CSCI.TO) has seen its stock price leap by 7.28% in the latest trading session. This impressive gain comes amidst a backdrop of investor interest and market activity that has sparked optimism around the company's future.
Investor takeaway: Investors should monitor COSCIENS Biopharma closely, as today's performance could signal growing confidence in its business strategy and market position.
Advertisement
COSCIENS Biopharma Inc.
CSCI.TO
CSCI.TO
COSCIENS Biopharma Inc.
Market cap
$8.08M
52W high
$14.80
52W low
$3.30
1W change
+1.47%
Beta
1.90
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CSCI's historical volatility
30-Day Vol
60.5%
Annualized
90-Day Vol
334.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$9.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$8.08 | C$6.55 – C$9.95 |
| 60 trading days | C$8.57 | C$6.38 – C$11.52 |
| 90 trading days | C$9.10 | C$6.34 – C$13.06 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
COSCIENS Biopharma Inc. up 7.28% in one day
The stock closed at CA$3.24, marking a significant increase in investor interest and market activity.
Bull case
The recent rise in COSCIENS Biopharma's stock may show that investors are feeling positive about the company. This could be driven by speculation about upcoming developments or strategic decisions that might boost its presence in the market.
Bear case
Even with today's gains, it's wise for investors to stay cautious. The lack of recent news from the company might suggest that this rally isn't backed by solid fundamentals, which could make the stock vulnerable to corrections.
Advertisement
Market Reaction
The stock's rise today can be attributed to increased trading volume and heightened investor interest. With a market cap of CA$10,030,101, COSCIENS Biopharma is drawing attention as a potential growth stock in the biopharmaceutical sector.
Investor Sentiment
Today's gain could reflect a broader trend in the biopharma market, where investors are looking for opportunities amidst ongoing developments. However, it's essential to approach with caution, as the absence of recent news may leave the stock susceptible to volatility. For more insights, check out our detailed analysis on COSCIENS Biopharma Inc..
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


